Oppenheimer & Co’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $483K | Buy |
19,816
+1,153
| +6% | +$28.1K | 0.01% | 1158 |
|
|
2025
Q1 | $387K | Buy |
+18,663
| New | +$387K | 0.01% | 1170 |
|
|
2022
Q3 | – | Sell |
-7,801
| Closed | -$245K | – | 1370 |
|
|
2022
Q2 | $245K | Sell |
7,801
-7,199
| -48% | -$226K | 0.01% | 1180 |
|
|
2022
Q1 | $689K | Buy |
15,000
+664
| +5% | +$30.5K | 0.01% | 886 |
|
|
2021
Q4 | $877K | Sell |
14,336
-4,093
| -22% | -$250K | 0.02% | 827 |
|
|
2021
Q3 | $1.38M | Sell |
18,429
-122
| -0.7% | -$9.11K | 0.03% | 629 |
|
|
2021
Q2 | $1.72M | Buy |
18,551
+3,645
| +24% | +$337K | 0.03% | 566 |
|
|
2021
Q1 | $1.32M | Buy |
14,906
+9,901
| +198% | +$879K | 0.03% | 603 |
|
|
2020
Q4 | $467K | Buy |
5,005
+470
| +10% | +$43.9K | 0.01% | 920 |
|
|
2020
Q3 | $289K | Buy |
+4,535
| New | +$289K | 0.01% | 997 |
|